Top Story

FOLFOXIRI plus bevacizumab improved outcomes, increased toxicity in metastatic colorectal cancer

October 22, 2014

Patients with metastatic colorectal cancer who received first-line treatment with bevacizumab plus FOLFOXIRI chemotherapy demonstrated significantly longer PFS than those treated with bevacizumab plus FOLFIRI chemotherapy, according to results of a randomized phase 3 study.

However, bevacizumab plus FOLFOXIRI was associated with higher rates of certain adverse events, results showed.

In the Journals

Risk-adjusted model reveals little variation in hospital readmissions after colorectal cancer surgery

October 22, 2014
Researchers who used a risk-adjusted model to evaluate readmission rates after colorectal cancer surgery found little variation between hospitals.The finding raises…
Meeting News Coverage

Incidence of small bowel tumors increased over the last decade

October 22, 2014
PHILADELPHIA — Small bowel tumor incidence rates have increased over the last decade among various ethnic groups, according to data presented at the ACG Annual…
Meeting News Coverage

Advanced histology in diminutive adenomas three-fold higher in CRC vs. screening patients

October 22, 2014
PHILADELPHIA — Advanced histology in lesions sized 9 mm or less occurred at a higher rate in patients with colorectal cancer compared with patients who underwent…
More News Headlines »
CME CNE
figure

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
figure

Nomogram predicted recurrence risk among women who underwent APBI

September 26, 2014
Jessica Wobb, MD, senior resident in radiation oncology at Beaumont Health System in Birmingham, Mich., describes how…
More »
CME
figure

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »